Lee 2019[16]
|
Women with IDA due to menorrhagia (Hb < 10 g/dL, ferritin < 30 ng/mL) |
Menorrhagia with heavy cyclical menstrual blood loss (>80 mL per cycle) over 3 cycles |
FCM group, n = 52 |
FCM: body weight < 50 kg (500 mg iron), > 50 kg (1000 mg iron), single dose |
FCM: 923.1 ± 207.3 mg (at single visit) |
2 wk |
Short Form-12 Health Survey (SF-12), no differences in outcomes between groups. |
|
|
|
IS group, n = 49 |
IS: Ganzoni formula. (200 mg/wk × 3 wk) |
IS: 939.1 ± 352.3 mg (over 3–8 visits) |
|
|
Jose 2019[17]
|
Pregnant women with IDA (Hb > 6.0 g/dL, < 10 g/dL) |
No active bleeding |
FCM group, n = 50 |
FCM: Ganzoni formula. (1000 mg single dose, repeated after days 7 and 14) |
FCM: 1739.6 ± 105.5 mg (over 2 wk) |
3, 6∗, 12 wk |
Fatigue (LASA; Linear Analogue Scale Assessment), lower in the FCM group compared with the IS group (P = 0.0048). |
|
|
|
IS group, n = 50 |
IS: Ganzoni formula. (300 mg twice/wk) |
IS: 1,730.4 ± 121.9 mg (over 3 wk) |
|
|
Naqash 2018[18]
|
Obstetric (pregnancy, postpartum) and gynecologic (menorrhagia, uterus heavy bleeding, ovarian cyst) patients with IDA |
Menorrhagia (bleeding for more than 7 d with heavy clots, and doubling of pads or tampons to manage menstrual flow), Uterus heavy bleeding (more than 12 d with doubling of pads or tampons to manage menstrual flow) |
FCM group, n = 100 |
FCM: Ganzoni formula (1000 mg single dose) |
FCM: no details provided. |
2, 4∗ wk |
Short Form 36 (SF-36), improved outcomes in the FCM group compared with the IS group (no comments for P value). |
|
|
|
IS group, n = 100 |
IS: Ganzoni formula (200 mg × 2–3 times) |
IS: no details provided. |
|
|
Sumathy 2017[19]
|
Postpartum women with IDA (Hb 8–10 g/dL) |
Normal postpartum women at 24 h after delivery |
FCM group, n = 50 |
FCM: modified Ganzoni formula (single dose) |
FCM: 937.94 mg |
2, 4∗ wk |
No details provided |
|
|
|
IS group, n = 50 |
IS: modified Ganzoni formula (200 mg/d × 5 times) |
IS: 935.53 mg |
|
|
Mahey 2016[20]
|
Women older than 18 years with heavy menorrhagia and IDA (Hb 6.0–10.9 g/dL) |
Menorrhagia with a pictorial bleeding assessment chart score higher than 100 |
FCM group, n = 30 |
FCM: modified Ganzoni formula (1000 mg single dose) |
FCM: no details provided |
1, 6∗, 12 wk |
Fatigue (LASA; Linear Analogue Scale Assessment), improved outcomes in both groups without any statistical differences |
|
|
|
IS group, n = 30 |
IS: modified Ganzoni formula (300 mg twice weekly) |
IS: no details provided |
|
|
Joshi 2016[21]
|
Postpartum women with IDA (Hb ≤ 6.0 g/dL, ≥ 11 g/dL) |
Postpartum women with significant vaginal bleeding in 24 h prior was excluded |
FCM group, n = 90 |
FCM: 1000 mg single dose |
FCM: 1000 mg |
30 d |
No details provided |
|
|
|
IS group, n = 83 |
IS: 200 mg × 5 times |
IS: 1000 mg |
|
|
Hol 2015[22]
|
Postpartum women with IDA (Hb, 7–11 g/dL)—moderate anemia group |
Postpartum women suffering from acute blood loss was excluded |
FCM group, n = 20 |
FCM: 500 mg × 2 times |
FCM, 500 mg |
1 d, 6∗ wk |
No details provided |
|
|
|
IS group, n = 20 |
IS: 200 mg × 4 times |
IS, 500 mg |
|
|
Garg 2015[23]
|
Postpartum women with IDA (Hb < 7 g/dL) |
All normal delivery and cesarean delivery patient |
FCM group, n = 50 |
FCM: body weight (kg) × [target Hb (11 g/dL) – actual Hb (g/dL)] × 0.24 + storage iron (500 mg), single dose |
FCM: no details provided |
2, 4∗ wk |
No details provided |
|
|
|
IS group, n = 50 |
IS: body weight (kg) × [target Hb (11 g/dL) —actual Hb (g/dL)] × 0.24 + storage iron (500 mg), 200 mg × 5 times |
IS: no details provided |
|
|
Rathod 2015[24]
|
Postpartum women with IDA (Hb < 10 g/dL) |
No details about the bleeding |
FCM group, n = 14 |
FCM: body weight (kg) × [target Hb (12 g/dL) —actual Hb (g/dL)] × 0.24 + storage iron (500 mg), single dose |
FCM: no details provided |
2, 6∗ wk |
General Well-Being Scale, higher scores in the FCM group compared with the IS group |
|
|
|
IS group, n = 22 |
IS: body weight (kg) × [target Hb (11 g/dL) —actual Hb (g/dL)] × 0.24 + storage iron (500 mg), 200 mg × 5 times |
IS: no details provided |
|
|